CIK 0001438533 · Large accelerated filer
Travere Therapeutics, Inc.
Sign in to watch- Ticker
- TVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 262383102
- Phone
- 888-969-7879
- Business address
- 3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Retrophin, Inc., Desert Gateway, Inc.
- 144 Insider Sale of Securities
- 4 Planned sale Chief Legal Officer and GC sold 10,000 shares at $27.34 ($273,420)
- 144 Insider Sale of Securities
- 8-K Event Other events
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Planned sale CHIEF MEDICAL OFFICER sold 2,476 shares at an average $39.74 ($98,404)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF COMMERCIAL OFFICER sold 4,980 shares at $40.00 ($199,200)
- 4 Planned sale Chief Research Officer sold 60,000 shares at $40.10 ($2,406,180)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 15,000 shares at $42.00 ($630,005)
- 4 Planned sale SVP, CHIEF ACCOUNTING OFFICER sold 7,402 shares at $40.00 ($296,080)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale SVP, CHIEF ACCOUNTING OFFICER sold 2,910 shares at $36.00 ($104,760)
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 20,000 shares at $35.01 ($700,202)
Page 9 of 65 · 1,286 filings